Vismodegib dose reduction effective when combined with itraconazole for the treatment of advanced basal cell carcinoma

Lignende værker

• Vismodegib dose reduction effective when combined with itraconazole for the treatment of advanced basal cell carcinoma
  af: Jaeyoung Yoon, MD, PhD
  Udgivet: (2021-01-01)
• Benefit–risk assessment of sonidegib and vismodegib in the treatment of locally advanced basal cell carcinoma
  af: Antonio J García Ruiz, et al.
  Udgivet: (2022-07-01)
• Sustained Suppression of Gorlin Syndrome-Associated Basal Cell Carcinomas with Vismodegib or Sonidegib: A Case Series
  af: Raquel Wescott, et al.
  Udgivet: (2023-10-01)
• The Efficacy of Sonidegib in Treating Locally Advanced Basal Cell Carcinoma Involving the Periocular Area
  af: Alessia Villani, et al.
  Udgivet: (2023-07-01)
• Real-World Treatment Patterns of Patients with Basal Cell Carcinoma Using Sonidegib and Vismodegib: Discontinuation Rates and Clinical Conditions During Treatment
  af: Mark G. Lebwohl, et al.
  Udgivet: (2025-12-01)